Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$1.85 - $3.81 $4.2 Million - $8.66 Million
-2,272,726 Reduced 80.0%
568,182 $1.07 Million
Q2 2023

Aug 14, 2023

SELL
$2.62 - $4.59 $2 - $4
-1 Reduced -0.0%
2,840,908 $10.4 Million
Q1 2021

May 17, 2021

BUY
$1.86 - $5.25 $5.28 Million - $14.9 Million
2,840,909 New
2,840,909 $9.52 Million

Others Institutions Holding ASLN

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0

About ASLAN Pharmaceuticals Ltd


  • Ticker ASLN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,744,704
  • Market Cap $41.8M
  • Description
  • ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...
More about ASLN
Track This Portfolio

Track Vivo Capital, LLC Portfolio

Follow Vivo Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivo Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vivo Capital, LLC with notifications on news.